The "Times" story and CFPPC investigation revealed that between April 2004 and the end of 2007, Marin had received in excess of $50,000 for various speaking engagements through the American Program Bureau lecture agency. Additionally, forms filed by a firm established by her and her husband, Marin and Marin, LLC, indicated that she received between $10,000 and $100,000 in speaking fees. The CFPPC was particularly concerned with $15,000 Marin received from the drug company Pfizer in 2007 which was simultaneously lobbying the Board of Pharmacy, a regulatory panel under her jurisdiction, and $13,500 from Bristol-Myers Squibb in 2008 when it was likewise lobbying agencies she oversaw. Marin countered that most of the speeches were "inspirational" in nature and that she had kept the governor's office and state senate informed since her appointment to the IWMB. The CFPPC had initially launched its investigation after a routine review found that Marin had listed her speaking engagement fees as income.